Table 3 Interventions for VAD related adverse events per venous access device
N (%) | Antibiotics (oral) | VAD replaced | Wait-and-see | Analgesics | Urokinase (IV) | Antibiotics (IV) |
|---|---|---|---|---|---|---|
Venous access port (102) | 19 (18.6) | 10 (9.8) | 13 (12.7) | 8 (7.8) | 8 (7.8) | 2 (2.0) |
Hickman line (15) | 1 (6.7) | 6 (40.0) | 3 (20.0) | 2 (13.3) | 1 (6.7) | 0 (0.0) |
PICC line (10) | 2 (20.0) | 3 (30.0) | 1 (10.0) | 0 (0.0) | 0 (0.0) | 3 (30.0) |
Total | 22 (17.3) | 19 (15.0) | 17 (13.4) | 10 (7.9%) | 9 (7.1) | 5 (3.9) |